NEW YORK, July 20 – Informatics software provider Scimagix said this week that it had raised $25 million in a third found of private financing.

Dresdner Kleinwort Capital and EuclidSR Partners led the financing round. Tullis-Dickerson, Invesco, Future Capital, and IngleWood Ventures also participated in the financing round. Daniel Green, a director at Dresdner Kleinwort Capital, and Barbara Dalton, a partner at EuclidSR Partners, will take seats on the company’s board of directors.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.